Bridgewater Wealth & Financial Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,148
Closed -$279K 117
2017
Q2
$279K Buy
2,148
+3
+0.1% +$368 0.09% 89
2017
Q1
$267K Buy
2,145
+19
+0.9% +$2.27K 0.1% 88
2016
Q4
$246K Hold
2,126
0.09% 95
2016
Q3
$222K Sell
2,126
-615
-22% -$66.6K 0.08% 103
2016
Q2
$270K Sell
2,741
-12
-0.4% -$1.24K 0.1% 88
2016
Q1
$276K Buy
2,753
+539
+24% +$55.5K 0.1% 87
2015
Q4
$265K Sell
2,214
-253
-10% -$29.3K 0.1% 74
2015
Q3
$267K Buy
+2,467
New +$306K 0.11% 71
2015
Q1
Sell
-2,404
Closed -$269K 100
2014
Q4
$269K Buy
+2,404
New +$254K 0.11% 85

Other funds holding CELG

Bridgewater Wealth & Financial Management's CELG Position: Q3 2017 in Review

Bridgewater Wealth & Financial Management sold out of Celgene Corp (CELG) in Q3 2017, closing a stake of 2,148 shares — an estimated $279K sold.

Bridgewater Wealth & Financial Management first reported a position in CELG in Q4 2014 and held it in 9 quarters. The position peaked at $279K in Q2 2017. 1,484 funds tracked by Wall St. Rank hold CELG as of Q3 2017.

  • Bridgewater Wealth & Financial Management reported no remaining Celgene Corp position as of Q3 2017 after selling out during the quarter.
  • Bridgewater Wealth & Financial Management sold 2,148 Celgene Corp shares in Q3 2017, an estimated $279K.
  • Bridgewater Wealth & Financial Management first reported a position in Celgene Corp in Q4 2014 and held it in 9 quarters.
  • Bridgewater Wealth & Financial Management's Celgene Corp position peaked at $279K in Q2 2017.
  • 1,484 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2017.

Based on Bridgewater Wealth & Financial Management's 13F filing for Q3 2017, filed 14 Nov 2017.